Further exploration in larger follow-up studies with a significantly larger sample size and complete demographic and genetic information are needed to validate these results and to definitively assess TSC2 mutation frequency, its association with tumor location, and the influence of genetic background and other factors on the oncogenic process. This evidence concerns the gene TSC2 and neoplasm.